| Bid Price | 1522.00p | High Price | 1535.00p |
|---|
| Ask Price | 1524.00p | Low Price | 1509.00p |
|---|
| Open Price | 1530.00p | Spread | 0.13% |
|---|
| Prev Close | 1528.00p | Volume | 459,397 |
|---|
Hikma Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 12, 2025 | 1530.00 | 1535.00 | 1509.00 | 1516.00 | 459,397 |
| Dec 11, 2025 | 1536.00 | 1537.00 | 1520.00 | 1528.00 | 517,398 |
| Dec 10, 2025 | 1540.00 | 1554.00 | 1530.00 | 1530.00 | 415,923 |
| Dec 9, 2025 | 1569.00 | 1575.00 | 1550.00 | 1550.00 | 776,316 |
| Dec 8, 2025 | 1592.00 | 1608.00 | 1562.00 | 1562.00 | 580,784 |
Hikma Pharmaceuticals PLC Information
| Name | Hikma Pharmaceuticals PLC | Index | FTSE 100 |
|---|
| ISIN | GB00B0LCW083 | Epic | HIK |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET1 |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 500 | Trading Status | Closed |
|---|
| Shares in Issue | 221.45 m | Prev Close | 1528.00p |
|---|
| PE Ratio | 12.155233 | Market Cap | £3.36 bn |
|---|
| Div Yield | 4.2 | Div per Share | $0.48 |
|---|
| EPS | $1.07 | Div Cover | 2.2228 |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | 0.069322 | DPS Growth (%) | 0.2735 |
|---|
| Current Ratio | 1.243677 | Quick Ratio | 0.634728 |
|---|
Hikma Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 11/11/25 | BUY | Said Darwazah | CEO | 60,000 @ £15.89 | £953,400.00 |
| 11/11/25 | BUY | Said Darwazah | CEO | 70,000 @ £15.41 | £1,078,700.00 |
| 11/11/25 | BUY | Said Darwazah | CEO | 100,000 @ £16.16 | £1,616,000.00 |
| 11/11/25 | BUY | Said Darwazah | CEO | 100,000 @ £16.05 | £1,605,000.00 |
| 11/11/25 | BUY | Said Darwazah | CEO | 100,000 @ £15.25 | £1,525,000.00 |
| 11/11/25 | BUY | Said Darwazah | CEO | 100,000 @ £15.92 | £1,592,000.00 |
| 07/11/25 | BUY | Mazen Darwazah | CH | 200,000 @ £16.07 | £3,214,000.00 |
| 07/11/25 | BUY | Mazen Darwazah | CH | 115,000 @ £15.90 | £1,828,500.00 |
| 07/11/25 | BUY | Victoria Hull | NED | 3,214 @ £15.47 | £49,721.00 |
| 23/09/25 | DRIP | Riad Mishlawi | CEO | 1,680 @ £16.30 | £27,384.00 |
Hikma Pharmaceuticals PLC News
